ERYTHROMYCIN- erythromycin tablet, film coated 
AbbVie Inc.

----------

ERYTHROMYCIN

PRINCIPAL DISPLAY PANEL - 250 mg Bottle Label

NDC 24338-102-13
100 Tablets

ERYTHROMYCIN
TABLETS, USP

Film-coated Tablets

250 mg
Erythromycin,
USP

Tablet identification code format
change adopted October, 2000.

Rx only

arbor
PHARMACEUTICALS, LLC



PRINCIPAL DISPLAY PANEL - 250 mg Bottle Label

PRINCIPAL DISPLAY PANEL - 500 mg Bottle Label

NDC 24338-104-13
100 Tablets

ERYTHROMYCIN
TABLETS, USP

Film-coated Tablets

500 mg
Erythromycin,
USP

Tablet identification code format
change adopted October, 2000.

Rx only

arbor
PHARMACEUTICALS, LLC



PRINCIPAL DISPLAY PANEL - 500 mg Bottle Label
ERYTHROMYCIN 
erythromycin tablet, film coated
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0051-6326
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Erythromycin (UNII: 63937KV33D) (Erythromycin - UNII:63937KV33D) Erythromycin250 mg
Inactive Ingredients
Ingredient NameStrength
Silicon Dioxide (UNII: ETJ7Z6XBU4)  
croscarmellose sodium (UNII: M28OL1HH48)  
crospovidone (UNII: 2S7830E561)  
D&C Red No. 30 (UNII: 2S42T2808B)  
aluminum oxide (UNII: LMI26O6933)  
hydroxypropyl cellulose (type H) (UNII: RFW2ET671P)  
hypromelloses (UNII: 3NXW29V3WO)  
hypromellose phthalate (24% phthalate, 55 CST) (UNII: 87Y6436BKR)  
magnesium stearate (UNII: 70097M6I30)  
cellulose, microcrystalline (UNII: OP1R32D61U)  
povidones (UNII: FZ989GH94E)  
polyethylene glycols (UNII: 3WJQ0SDW1A)  
propylene glycol (UNII: 6DC9Q167V3)  
sodium citrate (UNII: 1Q73Q2JULR)  
sodium hydroxide (UNII: 55X04QC32I)  
sorbic acid (UNII: X045WJ989B)  
sorbitan monooleate (UNII: 06XEA2VD56)  
talc (UNII: 7SEV7J4R1U)  
titanium dioxide (UNII: 15FIX9V2JP)  
Product Characteristics
ColorPINKScoreno score
ShapeOVALSize15mm
FlavorImprint Code EB
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0051-6326-13100 in 1 BOTTLE; Type 0: Not a Combination Product09/06/2011
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Approved Drug Product Manufactured Under ContractANDA06162109/06/2011
ERYTHROMYCIN 
erythromycin tablet, film coated
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0051-6227
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Erythromycin (UNII: 63937KV33D) (Erythromycin - UNII:63937KV33D) Erythromycin500 mg
Inactive Ingredients
Ingredient NameStrength
Silicon Dioxide (UNII: ETJ7Z6XBU4)  
croscarmellose sodium (UNII: M28OL1HH48)  
crospovidone (UNII: 2S7830E561)  
D&C Red No. 30 (UNII: 2S42T2808B)  
aluminum oxide (UNII: LMI26O6933)  
hydroxypropyl cellulose (type H) (UNII: RFW2ET671P)  
hypromelloses (UNII: 3NXW29V3WO)  
hypromellose phthalate (24% phthalate, 55 CST) (UNII: 87Y6436BKR)  
magnesium stearate (UNII: 70097M6I30)  
cellulose, microcrystalline (UNII: OP1R32D61U)  
povidones (UNII: FZ989GH94E)  
polyethylene glycols (UNII: 3WJQ0SDW1A)  
propylene glycol (UNII: 6DC9Q167V3)  
sodium citrate (UNII: 1Q73Q2JULR)  
sodium hydroxide (UNII: 55X04QC32I)  
sorbic acid (UNII: X045WJ989B)  
sorbitan monooleate (UNII: 06XEA2VD56)  
talc (UNII: 7SEV7J4R1U)  
titanium dioxide (UNII: 15FIX9V2JP)  
Product Characteristics
ColorPINKScoreno score
ShapeOVALSize19mm
FlavorImprint Code EA
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0051-6227-24100 in 1 BOTTLE; Type 0: Not a Combination Product09/06/2011
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Approved Drug Product Manufactured Under ContractANDA06162109/06/2011
Labeler - AbbVie Inc. (078458370)

Revised: 11/2017
Document Id: 13012917-0d0d-457b-9bca-ea9a0425f3d7
Set id: 1faa5559-3eb6-409a-bcf0-9165b76177e4
Version: 13
Effective Time: 20171103
 
AbbVie Inc.